Designed and discovered by Isis Pharmaceuticals, iCo-007 is a second-generation antisense drug targeting c-Raf kinase for the treatment of DME and diabetic retinopathy. In consideration for the technology
Vimovo is approved for the relief of the signs and symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients
Headquartered in Phillipsburg, New Jersey, Covidien’s specialty chemicals business, manufactures and markets high-purity chemicals and related products and services under two brand names, JT Baker and Mallinckrodt Laboratory
Systech SPT, a serialization solution for the global pharmaceutical industry, serializes products at the item, case, and pallet levels. The solution also enables bi-directional communication between the packaging
Nutra Pharma said that Nyloxin Rx is a prescription pain reliever clinically proven to treat Stage 3 (severe) chronic pain. Unlike Stage 2 pain, which interferes with both
The Debride WH-1 topical treatment product was developed by McCoy Enterprises, the same organisation responsible for creation of the buccal mucosa drug delivery system licensed to Spring Creek
Genzyme is expected to pay an up-front disgorgement of past profits of $175m. The company is expected to continue to ship Cerezyme (imiglucerase for injection) and Fabrazyme (agalsidase
Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is highly expressed on ALCL cells. Brentuximab vedotin (SGN-35) Phase II trial, which was initiated in June
Daclizumab is a humanised monoclonal antibody that binds to CD25, a receptor subunit that is expressed at low levels on resting T-cells and at high levels on T-cells
The effect of temperature on liquid chromatography (LC) separations is often crucial where closely eluting substances are being separated and therefore, where accurate data is required, precise temperatures
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.